Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,120.12
(
-0.26%
)
US TECH 100
26,388.00
(
0.33%
)
Dow Jones
48,743.77
(
-0.81%
)
Brent Oil
110.48
(
5.81%
)
Bitcoin
75,457.93
(
-1.16%
)
News Focus
News Focus
Post# of 257465
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122905
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rwwine post# 255469

Thursday, 06/12/2025 12:10:27 PM

Thursday, June 12, 2025 12:10:27 PM

Post# of 257465
BNTX acquires CVAC for ~$5.46/sh in stock—a 34% premium to yesterday’s closing price:

https://finance.yahoo.com/news/biontech-announces-strategic-transaction-acquire-104500109.html

Both companies are based in Germany and both are pursuing oncology programs based on mRNA. CVAC divested its COVID/flu program one year ago (#msg-174700357).

The exchange ratio is subject to a collar based on trading during a 10-day window prior to the deal closing. The nominal deal value is ~$1.25B.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today